Tourmaline Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	35.01	140.73	8.26	0.15
Short-Term Investments	246.92	62.23	-	-
Cash & Short-Term Investments	281.92	202.95	8.26	0.15
Cash Growth	261.24%	2357.63%	5405.33%	-
Prepaid Expenses	11.86	5.92	0.05	-
Total Current Assets	293.79	208.87	8.31	0.15
Property, Plant & Equipment	0.31	0.45	0.57	-
Other Long-Term Assets	1.89	0.97	0.22	-
Total Assets	328.45	210.3	9.1	0.15
Accounts Payable	2.05	1.07	0.4	0.19
Accrued Expenses	5	3.71	0.8	0.03
Short-Term Debt	-	-	-	0.15
Current Portion of Leases	0.23	0.22	0.16	-
Total Current Liabilities	7.28	5	1.36	0.38
Long-Term Leases	0.06	0.19	0.34	-
Other Long-Term Liabilities	0.03	0.06	-	-
Total Liabilities	7.38	5.25	1.71	0.38
Common Stock	0	0	-	-
Additional Paid-In Capital	433.27	267.02	0.2	-
Retained Earnings	-113.03	-62.05	-19.93	-0.23
Comprehensive Income & Other	0.82	0.07	-	-
Total Common Equity	321.07	205.04	-19.73	-0.23
Shareholders' Equity	321.07	205.04	7.39	-0.23
Total Liabilities & Equity	328.45	210.3	9.1	0.15
Total Debt	0.29	0.42	0.5	0.15
Net Cash (Debt)	281.63	202.54	7.75	-
Net Cash Growth	262.98%	2512.02%	-	-
Net Cash Per Share	12.30	42.67	8.84	-
Filing Date Shares Outstanding	25.64	25.65	10.88	10.88
Total Common Shares Outstanding	25.64	20.34	10.88	10.88
Working Capital	286.5	203.87	6.95	-0.23
Book Value Per Share	12.52	10.08	-1.81	-0.02
Tangible Book Value	321.07	205.04	-19.73	-0.23
Tangible Book Value Per Share	12.52	10.08	-1.81	-0.02
Machinery	-	0.05	0.02	-
Leasehold Improvements	-	0.07	0.06	-

Source: S&P Capital IQ. Standard template. Financial Sources.